Silke Reinartz Selected Research

Silke Reinartz Research Topics

Disease

16	Neoplasms (Cancer) 01/2020 - 06/2003
13	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 06/2003
9	Carcinoma (Carcinomatosis) 01/2022 - 03/2004
9	Ascites 01/2020 - 01/2014
4	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2018
1	Adenocarcinoma 09/2018
1	Chronic Pancreatitis 09/2018
1	Disease Progression 01/2016
1	Carcinogenesis 07/2012
1	Breast Neoplasms (Breast Cancer) 04/2009

Drug/Important Bio-Agent (IBA)

4	LipidsIBA 01/2022 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2016
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 06/2003
4	VaccinesIBA 01/2010 - 06/2003
4	abagovomabIBA 01/2010 - 06/2003
3	CytokinesIBA 01/2019 - 01/2014
3	Interleukin-10 (Interleukin 10)IBA 01/2018 - 01/2014
3	AntigensIBA 07/2012 - 06/2003
2	Arachidonic Acid (Vitamin F)IBA 01/2022 - 01/2021
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021 - 05/2015
2	Small Interfering RNA (siRNA)IBA 01/2020 - 07/2012
2	Conditioned Culture MediaIBA 01/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 09/2018 - 01/2018
2	Interleukin-12 (IL 12)IBA 01/2018 - 01/2017
2	LigandsIBA 01/2017 - 05/2015
2	Monoclonal AntibodiesIBA 09/2006 - 06/2003
1	Fibronectins (Fibronectin)IBA 01/2020
1	Calbindin 2IBA 01/2020
1	Collagen Type I (Type I Collagen)IBA 01/2020
1	TenascinIBA 01/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2019
1	P-2 (P 2)IBA 01/2019
1	Lysophosphatidic Acid ReceptorsIBA 01/2019
1	Secretory Phospholipases A2IBA 01/2019
1	lysophosphatidic acidIBA 01/2019
1	GlypicansIBA 09/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	ChromatinIBA 01/2018
1	Chemokine CXCL9IBA 01/2018
1	NK Cell Lectin-Like Receptor Subfamily KIBA 01/2017
1	Biological ProductsIBA 01/2017
1	InterferonsIBA 01/2017
1	Frizzled ReceptorsIBA 01/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2015
1	Linoleic Acid (Linoleate)IBA 05/2015
1	CA-125 Antigen (CA 125 Antigen)IBA 07/2012
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 04/2009
1	LY 117018IBA 04/2009
1	Raloxifene Hydrochloride (Evista)FDA Link 04/2009
1	Estrogen ReceptorsIBA 04/2009
1	Celecoxib (Celebrex)FDA Link 04/2009
1	Selective Estrogen Receptor Modulators (SERM)IBA 04/2009
1	Anti-Idiotypic AntibodiesIBA 06/2005
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2004
1	AntibodiesIBA 03/2004
1	CarbohydratesIBA 06/2003

Therapy/Procedure

3	Therapeutics 01/2018 - 01/2017
1	Drug Therapy (Chemotherapy) 01/2017
1	Investigational Therapies (Experimental Therapy) 01/2017